Bone stops Phase III of Preob cells in osteonecrosis for futility

By Brian Moy | Nov 9, 2018 | 6:26 PM GMT

Bone Therapeutics S.A. (Euronext:BOTHE) discontinued a Phase III trial of its Preob cells to treat osteonecrosis of